Andrew Malloy

Andrew Malloy has extensive experience in the biotechnology industry, with a focus on sales and marketing. Andrew began their career at NanoSight Limited, where they worked as a Sales Manager and later became the Global Sales and Distributor Manager. During their time at NanoSight, Andrew played a crucial role in developing the product and building a global distribution network. The company was eventually acquired by Malvern Instruments, where Andrew continued their role as the Global Nanotechnologies Sales Manager. Andrew was responsible for overseeing the transition of sales and marketing activities from NanoSight to Malvern Instruments, as well as monitoring market dynamics and maintaining customer relationships. In 2016, Andrew joined Oxford Nanoimaging Limited as the CEO, where they focused on business plan development and securing funding. Andrew then moved to NanoView Biosciences as the VP of Sales and Marketing, where they developed and implemented a successful sales and marketing plan. Currently, Andrew is working at Unchained Labs as the Senior Director Of Sales Europe and ROW and will transition to the role of VP of Biologics and Gene Therapy EMEA in 2024.

Andrew Malloy's education history includes obtaining a Bachelor of Engineering (BEng) and a Master of Science (MSc) degree in Biomedical Engineering from the University of Liverpool, during the years 2000 to 2004. Andrew later pursued a Master of Business Administration (M.B.A.) from the same university, completing it from 2012 to 2016.